Real world Increased Nuchal Translucency & Genetic Risk

Increased Nuchal Translucency & Genetic RISK

Thickness matters — exponentially

Risk does not rise linearly. Once NT crosses 3.5 mm, the slope of risk increase becomes steep.

Septation changes the biology

• Non-septated NT → often hemodynamic/transient.
• Septated NT → implies lymphatic developmental abnormality.
• Large + septated = cystic hygroma physiology, not just “big NT.”

Chromosomal distribution shifts with thickness

• 3.5–4.5 mm → more T21
• 5 mm → rising Turner, T18, T13
• Very large septated NT → Turner predominates

If karyotype/CMA is normal

Residual risk depends heavily on:

• NT thickness
• Septation
• Cardiac findings
• Evolution over time (transient vs persistent)

For example:

• 3.8 mm, non-septated, resolves by 14 weeks → >90% chance of normal outcome.
• 6 mm, septated, persists → high risk even if CMA normal.

NT Thickness, Septation & Genetic RISK

NT Thickness (mm)	Septation	Aneuploidy Risk	Major Structural Defect Risk	Genetic Syndrome (RASopathy, single-gene)	IUFD Risk	Overall Prognostic Impression
2.5–3.4 mm	No	~1–3%	~2–4%	<1%	<1%	Often physiologic variant
2.5–3.4 mm	Yes	~5–10%	~5–8%	~2–3%	1–2%	Mildly concerning
3.5–4.4 mm	No	~10–20%	~8–15%	~3–5%	2–5%	Moderate risk
3.5–4.4 mm	Yes	~25–40%	~15–25%	~5–10%	5–10%	High risk
4.5–5.4 mm	No	~25–40%	~20–30%	~8–15%	5–15%	High risk
4.5–5.4 mm	Yes	~50–70%	~30–50%	~15–20%	15–25%	Very high risk
5.5–6.4 mm	No	~40–60%	~30–50%	~15–20%	15–30%	Very high risk
5.5–6.4 mm	Yes	~70–85%	~40–60%	~20–30%	25–40%	Poor prognosis
≥6.5 mm	No	~50–70%	~40–60%	~20–30%	30–50%	Severe risk
≥6.5 mm	Yes (cystic hygroma pattern)	70–90%	50–70%	25–35%	40–60%	Very poor prognosis

Pathophysiology

Pattern	Likely Mechanism
Mild non-septated	Transient hemodynamic imbalance
Moderate persistent	Cardiac preload/afterload imbalance
Large septated	Lymphatic developmental failure
Massive + hydrops	Cardiac failure or chromosomal

Mild isolated NT (3.0–3.4 mm, non-septated)

With a normal CMA:

• Risk is only slightly above baseline
• Prognosis is excellent
• Most babies are normal

This group often behaves like a physiologic fluid imbalance.

NT 3.5–4.5 mm, no septation

After normal CMA:

• Residual risk is mainly cardiac
• RASopathy risk exists but is modest
• If NT resolves and fetal echo is normal → outcome approaches 90%

This is the “transitional zone” group.

Large NT (>4.5 mm)

• Lymphatic development becomes more relevant
• Cardiac disease risk rises
• Single-gene disorders (especially RASopathies) become meaningful

Even with normal CMA, this is not low risk.

Septated NT / Cystic Hygroma

If septations are present:

• Think primary lymphatic dysplasia physiology
• Risk remains significant even if chromosomes are normal
• Resolution improves outlook but does not normalize risk

If CMA is normal:

• Small NT increase → prognosis very reassuring.
• Moderate NT (3.5–4.5) → mostly good, but fetal echo is key.
• Large NT (>4.5) → meaningful residual risk remains.
• Septated NT → risk remains elevated even with normal genetics.
• Resolution improves outlook substantially.